U.S. flag

An official website of the United States government

NM_000286.3(PEX12):c.182_184dup (p.Glu61_Ile62insLys) AND Peroxisome biogenesis disorder 3A (Zellweger)

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
May 6, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001035823.6

Allele description

NM_000286.3(PEX12):c.182_184dup (p.Glu61_Ile62insLys)

Gene:
PEX12:peroxisomal biogenesis factor 12 [Gene - OMIM - HGNC]
Variant type:
Duplication
Cytogenetic location:
17q12
Genomic location:
Preferred name:
NM_000286.3(PEX12):c.182_184dup (p.Glu61_Ile62insLys)
HGVS:
  • NC_000017.11:g.35577534_35577536dup
  • NG_008447.1:g.6102_6104dup
  • NM_000286.3:c.182_184dupMANE SELECT
  • NP_000277.1:p.Glu61_Ile62insLys
  • NC_000017.10:g.33904552_33904553insTTT
  • NC_000017.10:g.33904553_33904555dup
  • NM_000286.2:c.182_184dup
  • NM_000286.2:c.182_184dupAAA
Links:
dbSNP: rs1412916235
NCBI 1000 Genomes Browser:
rs1412916235
Molecular consequence:
  • NM_000286.3:c.182_184dup - inframe_insertion - [Sequence Ontology: SO:0001821]

Condition(s)

Name:
Peroxisome biogenesis disorder 3A (Zellweger)
Synonyms:
PEROXISOMAL BIOGENESIS DISORDER 3A (ZELLWEGER); Peroxisome biogenesis disorder 3A
Identifiers:
MONDO: MONDO:0013927; MedGen: C3553929; Orphanet: 912; OMIM: 614859

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV001199161Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))		Uncertain significance
(May 6, 2022) 		germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Invitae, SCV001199161.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

This variant, c.182_184dup, results in the insertion of 1 amino acid(s) of the PEX12 protein (p.Glu61_Ile62insLys), but otherwise preserves the integrity of the reading frame. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with PEX12-related conditions. ClinVar contains an entry for this variant (Variation ID: 550849). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Apr 6, 2024